Medical device maker Allergan is recalling its entire line of textured breast implants, weeks after dismissing evidence linking them with a rare cancer.

Earlier this month, the TGA announced it was proposing to ban 25 textured implants and tissue expanders after concluding they were associated with a higher risk of developing anaplastic large cell lymphoma.

The announcement followed a six-month investigation involving surface tests of each product and analysis of their association with the cancer.

As a result, they recommended the immediate cancellation of nine Allergan Natrelle branded products and suspension of a further 16 products pending their likely cancellation from the approved goods register.